Samsung Bioepis Co Ltd
General
Total Cases34
Active Cases5
Patents14
Ratings
Experience
Grade
Trend
DCT
L1
D
PTAB
L4
A
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 10/21/24 | STIPULATION AND ORDER REGARDING CASE MANAGEMENT. Signed by Chief District Judge Thomas S. Kleeh on 10/21/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 10/21/2024) | |
| 10/17/24 | SUMMONS Returned Executed as to Samsung Bioepis, CO., LTD., served on 10/16/2024. (Pogue, David) (Entered: 10/17/2024) | |
| 10/16/24 | PROOF OF SERVICE filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM (Pogue, David) (Entered: 10/16/2024) | |
| 10/15/24 | STIPULATION and Proposed Order Regarding Case Management by Celltrion, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM(Gottlieb, Max) (Entered: 10/15/2024) | |
| 09/30/24 | ORDER GRANTING MOTIONS FOR ALTERNATIVE SERVICE. The following motions are GRANTED: Civil Action No. 1:23-CV-89, ECF No. 43 ; Civil Action No. 1:23-CV-94, ECF No. [38] ; and, Civil Action No. 1:23-CV-97, ECF No. 31. Signed by Chief District Judge Thomas S. Kleeh on 09/30/2024. (snc) (Entered: 09/30/2024) | |
| 09/30/24 | ORDER DENYING DEFENDANT'S MOTIONS TO DISMISS. The Court DENIES WITHOUT PREJUDICE Defendant's motion (ECF No. [47] . Defendant is granted LEAVE TO REFILE its motion challenging jurisdiction after the Federal Circuit addresses the appeal of ECF No. 243. Any such refiled motion shall be filed within fifteen (15) days after the Federal Circuit issues its decision. Signed by Chief District Judge Thomas S. Kleeh on 09/30/2024. (snc) (Entered: 09/30/2024) | |
| 09/27/24 | RESPONSE to Motion re (27 in 1:24-cv-00053-TSK, 334 in 1:24-md-03103-TSK-JPM, 261 in 1:23-cv-00106-TSK-JPM, 266 in 1:23-cv-00097-TSK-JPM, 254 in 1:24-cv-00039-TSK-JPM, 278 in 1:23-cv-00094-TSK-JPM, 215 in 1:23-cv-00089-TSK-JPM) MOTION for Status Conference filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 09/27/2024) | |
| 09/16/24 | ORDER of USCA for the Federal Circuit as to [259] Notice of Appeal filed by Samsung Bioepis Co., Ltd., [190] Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., [258] Notice of Appeal filed by Samsung Bioepis, CO., LTD., [175] Notice of Appeal, filed by Samsung Bioepis, CO., LTD., [203] Notice of Appeal, filed by Formycon AG, 261 Notice of Appeal filed by Formycon AG, [176] Notice of Appeal, filed by Samsung Bioepis Co., Ltd. (snc) Modified to adjust filing date on 9/16/2024 (snc). (Entered: 09/16/2024) | |
| 09/16/24 | ORDER of USCA for the Federal Circuit as to [259] Notice of Appeal filed by Samsung Bioepis Co., Ltd., [190] Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., [258] Notice of Appeal filed by Samsung Bioepis, CO., LTD., 175 Notice of Appeal, filed by Samsung Bioepis, CO., LTD., [203] Notice of Appeal, filed by Formycon AG, [261] Notice of Appeal filed by Formycon AG, 176 Notice of Appeal, filed by Samsung Bioepis Co., Ltd. (snc) Modified to adjust filing date on 9/16/2024 (snc). (Entered: 09/16/2024) | |
| 09/13/24 | MOTION for Status Conference by Amgen, Inc., Celltrion, Inc., Formycon AG, Samsung Bioepis, CO., LTD.,. (Attachments: # [1] Exhibit Ex. A, # [2] Exhibit Ex. B, # [3] Exhibit Ex. C, # [4] Exhibit Ex. D)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Gottlieb, Max) (Entered: 09/13/2024) |